SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881105058572v1
20/4/518    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cole, J. C.
Right arrow Articles by Sumnall, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cole, J. C.
Right arrow Articles by Sumnall, H. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*3,4-METHYLENEDIOXYMETHAMPHETAMINE
Medline Plus Health Information
*Club Drugs
*Drug Abuse
*Drugs and Young People
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The effects of stereotype threat on cognitive function in ecstasy users

J. C. Cole

K. Michailidou

Psychology Department, Liverpool University, Liverpool, UK.

L. Jerome

Multidisciplinary Association for Psychedelic Studies, Sarasota, FL, USA.

H. R. Sumnall

Centre for Public Health, Liverpool John Moores University, Liverpool, UK.

Stereotype threat occurs when individuals, believed to be intellectually inferior, perform badly on cognitive tests they perceive to confirm stereotypes about them. Due to the wide media coverage of studies purporting to show cognitive deficits in ecstasy users it is possible that they experience stereotype threat. This study tested ecstasy and nonecstasy using polysubstance misusers on a variety of cognitive tests after they had been exposed to stereotype threat. This priming consisted of exposing them to information about the long-term effects of ecstasy which either stated that ecstasy caused memory loss or that it did not. Ecstasy users that had been primed that ecstasy did not cause cognitive deficits performed better than the other three groups on the delayed portion of the prose recall task from the Rivermead Behavioural Memory Test battery. There were no other statistically significant differences between any of the groups on any of the other cognitive tests used. This suggests that stereotype threat exists in ecstasy users and may be influencing their performance in experiments designed to identify cognitive deficits. In order to prevent this occurring in future studies, experimenters must be careful how they conduct their experiments and discuss their results with the media.

Key Words: ecstasy • MDMA • stereotype threat • cognition • polysubstance misuse

This version was published on July 1, 2006

Journal of Psychopharmacology, Vol. 20, No. 4, 518-525 (2006)
DOI: 10.1177/0269881105058572


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
G. Bedi and J. Redman
Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
J Psychopharmacol, November 1, 2008; 22(8): 872 - 881.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
T. S. Krebs and P.-O. Johansen
No Evidence of Decrease in Cognitive Function in Users of Low-Dose Ecstasy
Arch Gen Psychiatry, February 1, 2008; 65(2): 236 - 236.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
H. R Sumnall and M. A Bellis
Can health campaigns make people ill? The iatrogenic potential of population-based cannabis prevention
J Epidemiol Community Health, November 1, 2007; 61(11): 930 - 931.
[Full Text] [PDF]



Advertisement